Biogen Seeking Deals to Expand Pipeline

Biogen is ‘very actively’ searching for companies that have multiple sclerosis drugs in the early stages of research and development while also considering opportunities in other indications. Biogen, the world’s largest maker of MS drugs, recently narrowed its focus to neurodegenerative diseases and currently has a Phase III trial underway for dexpramipexole, a potential ALS treatment.

Click here to read more.

Share this: